Pharmaceutical Cocrystals: A Perspective

IF 3.4 2区化学 Q2 CHEMISTRY, MULTIDISCIPLINARY

Crystal Growth & Design Pub Date : 2025-08-25 DOI:10.1021/acs.cgd.5c00625

Binoy K. Saha*, and , Velina Rani Boro,

引用次数: 0

Abstract

In this perspective, the importance of pharmaceutical multicomponent systems, especially pharmaceutical cocrystals, in improving the bioavailability and other physicochemical properties of APIs has been discussed. How this field is being developed by the researchers using the concepts used in the field of crystal engineering, and the limitations and advantages of the pharmaceutical multicomponent systems, has also been discussed.

Abstract Image

查看原文本刊更多论文

药物共晶：一个视角

从这个角度来看，讨论了药物多组分系统，特别是药物共晶在提高原料药的生物利用度和其他物理化学性质方面的重要性。研究人员如何利用晶体工程领域的概念发展这一领域，以及药物多组分系统的局限性和优势，也进行了讨论。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Crystal Growth & Design 化学-材料科学：综合

CiteScore

6.30

自引率

10.50%

发文量

650

审稿时长

1.9 months

期刊介绍： The aim of Crystal Growth & Design is to stimulate crossfertilization of knowledge among scientists and engineers working in the fields of crystal growth, crystal engineering, and the industrial application of crystalline materials. Crystal Growth & Design publishes theoretical and experimental studies of the physical, chemical, and biological phenomena and processes related to the design, growth, and application of crystalline materials. Synergistic approaches originating from different disciplines and technologies and integrating the fields of crystal growth, crystal engineering, intermolecular interactions, and industrial application are encouraged.